UPCOMING SERIES: Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC

Trinity Bivalacqua, MD, PhD, announces an upcoming UroView series highlighting key information presented at ASCO 2024 surrounding treatment of high-risk BCG-unresponsive NMIBC.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -0:00

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Now Viewing

EP: 1.UPCOMING SERIES: Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC

Related Videos

RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice

RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC

RX Review: A paradigm shift for low-grade, intermediate-risk NMIBC

RX Review: How mitomycin for intravesical solution works in treating LG-IR-NMIBC

RX Review: Redefining treatment for LG-IR-NMIBC

The Logistical Challenges in ccRCC Treatment

The Role of Genomic Classifiers in Guiding Therapy for Localized High-Risk Prostate Cancer

The Future of PET Imaging Agents

A 62-Year-Old Man With High-Risk Localized Prostate Cancer

Ongoing Investigations: Expanding the Role of Cretostimogene in NMIBC Care

Related Content

Advertisement

June 2nd 2025

Survey: New NMIBC treatments face slow uptake

Benjamin P. Saylor

Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.

June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD

Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.

April 27th 2025

Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

Patrick Campbell

A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.

June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD

The conversation covers practical, case-based strategies for counseling MSM patients.

April 26th 2025

ADAM, a long-term, injectable male birth control, shows promise at AUA 2025

Patrick Campbell

A groundbreaking male contraceptive shows promising safety results, offering a reversible option for couples seeking effective birth control.

April 26th 2025

TikTok, social media does more harm than good for prostate cancer education

Patrick Campbell

Social media spreads significant misinformation about prostate cancer. Experts urge clinicians to provide trusted information sources.

Related Content

ClinicalDeep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC

Clinical

|

Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC

Advertisement

June 2nd 2025

Survey: New NMIBC treatments face slow uptake

Benjamin P. Saylor

Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.

June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD

Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.

April 27th 2025

Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

Patrick Campbell

A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.

June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD

The conversation covers practical, case-based strategies for counseling MSM patients.

April 26th 2025

ADAM, a long-term, injectable male birth control, shows promise at AUA 2025

Patrick Campbell

A groundbreaking male contraceptive shows promising safety results, offering a reversible option for couples seeking effective birth control.

April 26th 2025

TikTok, social media does more harm than good for prostate cancer education

Patrick Campbell

Social media spreads significant misinformation about prostate cancer. Experts urge clinicians to provide trusted information sources.